(ℹ) Join us now at the IRC channel | ䷉ Find the plain text version at this address.
*GNUmoon has quit (Ping timeout: 268 seconds) | Mar 19 05:22 | |
*GNUmoon (~GNUmoon@gateway/tor-sasl/gnumoon) has joined #techbytes | Mar 19 06:37 | |
*rianne_ has quit (Read error: Connection reset by peer) | Mar 19 12:10 | |
*rianne__ (~rianne@host81-154-169-167.range81-154.btcentralplus.com) has joined #techbytes | Mar 19 12:10 | |
schestowitz__ | http://ipkitten.blogspot.com/2021/03/second-medical-use-dosage-regieme-claim.html?showComment=1616147468775#c5759223075214048811 | Mar 19 15:23 |
---|---|---|
-TechBytesBot/#techbytes-ipkitten.blogspot.com | Second medical use dosage regimen claim successfully traverses both insufficiency and "obvious-to-try" attacks (T 0799/16) - The IPKat | Mar 19 15:23 | |
schestowitz__ | "Is the EPO becoming more relaxed in their decisions regarding dosage regimens - see T 2015/20?" | Mar 19 15:23 |
schestowitz__ | http://ipkitten.blogspot.com/2021/03/board-of-appeal-in-t180715-continues.html?showComment=1616146269395#c2765795372808712717 | Mar 19 15:23 |
-TechBytesBot/#techbytes-ipkitten.blogspot.com | BREAKING: Board of Appeal in T1807/15 continues with ViCo oral proceedings referral - The IPKat | Mar 19 15:23 | |
schestowitz__ | " | Mar 19 15:23 |
schestowitz__ | No, I meant Art. 2(3) of the EBA Business Scheme mentioned by Kant: | Mar 19 15:23 |
schestowitz__ | Where a regular member has participated in a case referred to the Enlarged Board of Appeal or in a decision which is the subject of a referral of the President of the European Patent Office, the Chairman shall... | Mar 19 15:23 |
schestowitz__ | It seems to me that this article does not apply, since the two conditions to exclude members are not met in this case. | Mar 19 15:23 |
schestowitz__ | " | Mar 19 15:24 |
schestowitz__ | http://ipkitten.blogspot.com/2021/03/board-of-appeal-in-t180715-continues.html?showComment=1616140440201#c4651948547265198381 | Mar 19 15:25 |
-TechBytesBot/#techbytes-ipkitten.blogspot.com | BREAKING: Board of Appeal in T1807/15 continues with ViCo oral proceedings referral - The IPKat | Mar 19 15:25 | |
schestowitz__ | " | Mar 19 15:25 |
schestowitz__ | The EPO is more and more developing into a banana republic with the help of the EBA. | Mar 19 15:25 |
schestowitz__ | It is tragic. | Mar 19 15:25 |
schestowitz__ | I only think that appealing to national authorities can put a stop to this dangerous way. | Mar 19 15:25 |
schestowitz__ | After all the EPO is not there to serve the top management and the minions gravitating around it, but to the users of the EPO. | Mar 19 15:25 |
schestowitz__ | " | Mar 19 15:25 |
schestowitz__ | http://ipkitten.blogspot.com/2021/03/board-of-appeal-in-t180715-continues.html?showComment=1616139859985#c372382031449403640 | Mar 19 15:25 |
-TechBytesBot/#techbytes-ipkitten.blogspot.com | BREAKING: Board of Appeal in T1807/15 continues with ViCo oral proceedings referral - The IPKat | Mar 19 15:25 | |
schestowitz__ | "Does anybody know what happend in the oral proceedings per ViCo in R7/19 (https://register.epo.org/application?number=EP02710558&lng=en&tab=doclist)?" | Mar 19 15:25 |
-TechBytesBot/#techbytes-register.epo.org | European Patent Register | Mar 19 15:25 | |
*Helios2 (~helios@cpc116422-epso6-2-0-cust323.6-3.cable.virginm.net) has joined #techbytes | Mar 19 19:49 | |
schestowitz__ | https://twitter.com/KaosInControl/status/1372877302288281603 | Mar 19 20:28 |
-TechBytesBot/#techbytes-@KaosInControl: https://t.co/Mn6J9CzWgS | Mar 19 20:28 | |
-TechBytesBot/#techbytes--> techrights.org | EPO and Microsoft Collude to Break the Law — Part XII: Foreign Corrupt Practices, Bid Rigging and “Slush Funds” | Techrights | Mar 19 20:28 | |
*Helios2 has quit (Ping timeout: 246 seconds) | Mar 19 21:03 | |
*Helios2 (~helios@cpc116422-epso6-2-0-cust323.6-3.cable.virginm.net) has joined #techbytes | Mar 19 21:19 | |
*Helios2 is now known as Arthur_S | Mar 19 21:39 | |
*Arthur_S is now known as Helios2 | Mar 19 21:53 | |
*Helios2 has quit (Quit: Leaving) | Mar 19 21:54 |
Generated by irclog2html.py
2.6 | ䷉ find the plain text version at this address.